[Prophylaxis of tuberculosis with BCG vaccine in children from contact and from unknown contact]. 2005

P V Khadeeva, and L V Mikhaleva, and Iu A Morozov

The quality and efficiency of immunoprophylaxis against tuberculosis have been studied in 563 children, by estimating the vaccination BCG signs. The children who have familial contacts and have been rather fully (92.3%) and effectively inoculated with BCG vaccination and in whom skin scars, 4-7 mm in diameter, have formed are at a high risk of tuberculosis due to massive infection in the bacterial isolation foci. Inadequate immunobiological defense reactions promote the progression of endogenous infection and the development of active tuberculosis in the vast majority (67.8%) children who have unestablished and unvaccinated or ineffectively vaccinated with BCG, infected under the occult bacterial isolation conditions mainly in the families where the adults have residual pulmonary changes and hypersensitivity to tuberculin the absence of immunobiological defensive reactions is the major risk factor for active tuberculosis.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

P V Khadeeva, and L V Mikhaleva, and Iu A Morozov
January 1970, Duodecim; laaketieteellinen aikakauskirja,
P V Khadeeva, and L V Mikhaleva, and Iu A Morozov
February 2004, Journal of tropical pediatrics,
P V Khadeeva, and L V Mikhaleva, and Iu A Morozov
January 1948, Archiv fur Kinderheilkunde,
P V Khadeeva, and L V Mikhaleva, and Iu A Morozov
January 1968, Pediatriia akusherstvo i ginekologiia,
P V Khadeeva, and L V Mikhaleva, and Iu A Morozov
January 1980, Sovetskaia meditsina,
P V Khadeeva, and L V Mikhaleva, and Iu A Morozov
September 1983, Pediatrics,
P V Khadeeva, and L V Mikhaleva, and Iu A Morozov
March 2020, The Journal of infectious diseases,
P V Khadeeva, and L V Mikhaleva, and Iu A Morozov
May 1947, Schweizerische Blatter fur Krankenpflege. Revue suisse des infirmieres,
P V Khadeeva, and L V Mikhaleva, and Iu A Morozov
July 1947, Schweizerische Blatter fur Krankenpflege. Revue suisse des infirmieres,
P V Khadeeva, and L V Mikhaleva, and Iu A Morozov
June 1947, Schweizerische Blatter fur Krankenpflege. Revue suisse des infirmieres,
Copied contents to your clipboard!